The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Clonal hematopoiesis in sickle cell disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with other recent reports43,44, the specific mutagenic processes driving this seem to be heterogeneous between patients, with no unique molecular signature associated with SCD.”
From Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Somatic mutations precede acute myeloid leukemia years before diagnosis
Desai, P., Mencia-Trinchant, N., Savenkov, O., Simon, M. S., Cheang, G., Lee, S., Samuel, M., Ritchie, E. K., Guzman, M. L., Ballman, K. V., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0081-z · Cited by 619
Self-citation
Research works printed but not linked: 21
- Ware, 2017, Sickle cell disease, Lancet., 390, 311, 10.1016/S0140-6736(17)30193-9 · DOI
- Warren, 2020, Clonal hematopoiesis and risk for hematologic malignancy, Blood., 136, 1599
- Xia, 2018, Somatic mutations and clonal hematopoiesis in congenital neutropenia, Blood., 131, 408, 10.1182/blood-2017-08-801985 · DOI
- Tsai, 2020, Clonal hematopoiesis in the inherited bone marrow failure syndromes, Blood., 136, 1615
- Kennedy, 2021, Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome, Nat Commun., 12, 1334, 10.1038/s41467-021-21588-4 · DOI
- Brunson, 2017, Increased risk of leukemia among sickle cell disease patients in California, Blood., 130, 1597, 10.1182/blood-2017-05-783233 · DOI · Paper page
- Seminog, 2016, Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study, J R Soc Med., 109, 303, 10.1177/0141076816651037 · DOI · Paper page
- Li, 2019, Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature, Mod Pathol., 32, 1712, 10.1038/s41379-019-0325-6 · DOI · Paper page
- Ghannam, 2020, Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation, Blood., 135, 1185
- Magrin, 2019, Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies, Blood., 134, 1203, 10.1182/blood.2019000949 · DOI
- Kassim, 2017, Hematopoietic stem cell transplantation for sickle cell disease: the changing landscape, Hematol Oncol Stem Cell Ther., 10, 259, 10.1016/j.hemonc.2017.05.008 · DOI
- Gaston, 1982, The cooperative study of sickle cell disease: review of study design and objectives, Am J Pediatr Hematol Oncol., 4, 197
- Bartolucci, 2012, Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis, Blood., 120, 3136, 10.1182/blood-2012-04-424184 · DOI
- Belbin, 2021, Toward a fine-scale population health monitoring system, Cell., 184, 2068, 10.1016/j.cell.2021.03.034 · DOI
- Lek, 2016, Analysis of protein-coding genetic variation in 60,706 humans, Nature., 536, 285, 10.1038/nature19057 · DOI · Paper page
- Alexandrov, 2020, The repertoire of mutational signatures in human cancer, Nature., 578, 94, 10.1038/s41586-020-1943-3 · DOI · Paper page
- Liggett, Clonal hematopoiesis in sickle cell disease, medRxiv.
- El Hoss, 2021, Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease, Haematologica., 106, 2707, 10.3324/haematol.2020.265462 · DOI
- Ortmann, 2019, Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation, Cell Rep., 27, 2022, 10.1016/j.celrep.2019.04.064 · DOI
- Slavin, 2019, Association between clonal hematopoiesis and late nonrelapse mortality after autologous hematopoietic cell transplantation, Biol Blood Marrow Transplant., 25, 2517, 10.1016/j.bbmt.2019.08.013 · DOI
- Soerensen, 2020, Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation, Blood Adv., 4, 885, 10.1182/bloodadvances.2019001157 · DOI
Cited by
Clonal hematopoiesis: Mutation-specific adaptation to environmental change
Florez, M. A., Tran, B. T., Wathan, T. K., DeGregori, J., Pietras, E. M., & King, K. Y. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.05.006 · Cited by 129
Clonal hematopoiesis and inflammation – the perpetual cycle
Avagyan, S., & Zon, L. I. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.12.001 · Cited by 79
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease
Spencer Chapman, M., Cull, A. H., Ciuculescu, M. F., Esrick, E. B., Mitchell, E., Jung, H., O’Neill, L., Roberts, K., Fabre, M. A., Williams, N., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02636-6 · Cited by 67
Metadata
- Authors
- Pincez, T., Lee, S. S. K., Ilboudo, Y., Preuss, M., Pham Hung d’Alexandry d’Orengiani, A.-L., Bartolucci, P., Galactéros, F., Joly, P., Bauer, D. E., Loos, R. J. F., Lindsley, R. C., & Lettre, G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2021-11-25
- Volume
- 138
- Issue
- 21
- Pages
- 2148-2152
- ISSN
- 0006-4971
- 1528-0020
- Cited by
- 66
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
